07/07/2009
€11M Investment At Cork Plant Announced
The Tánaiste has announced pharmaceutical company Pfizer is to invest over €11 million in the establishment of an R&D facility in Cork.
Pfizer, one of the world’s largest research-based biomedical and pharmaceutical companies will establish an R&D Kilo Technology Laboratory at its Ringaskiddy site in Cork.
Mary Coughlan said the project has been launched with the support of Government through IDA Ireland. The new laboratory will be a dedicated R&D facility within the
Process Development Centre (PDC) at the site and will research, develop and create new manufacturing technology for Pfizer’s facilities around the world.
The new state-of-the-art development facility will incorporate an early stage laboratory and is currently under construction.
Making the announcement the Tánaiste said: "This is a highly strategic project for the pharmaceutical industry and will significantly enhance Ireland's image as a location for innovative R&D.
"In addition, as it involves the co-location of substantial R&D and manufacturing it will be a leading example to other global companies of what can be achieved in Ireland.
"This investment is excellent news for the Cork site."
This year Pfizer is celebrating forty years in Ireland. Its Ringaskiddy site, employing over 550 people, consists of four API (bulk pharmaceutical) plants producing a range of material for many of Pfizer’s major products. Pfizer, which has eight
different operations in Ireland employing a total of 2,000 people.
Dr Paul Duffy, VP Pfizer Manufacturing Ireland/Singapore said: "Pfizer in Ireland has a proven track record in relation to process improvement and optimisation. The decision to invest in the Cork PDC was based on demonstrated technical competence with similar projects and the successful completion of a number of R&D programmes."
(DW/BMcC)
Pfizer, one of the world’s largest research-based biomedical and pharmaceutical companies will establish an R&D Kilo Technology Laboratory at its Ringaskiddy site in Cork.
Mary Coughlan said the project has been launched with the support of Government through IDA Ireland. The new laboratory will be a dedicated R&D facility within the
Process Development Centre (PDC) at the site and will research, develop and create new manufacturing technology for Pfizer’s facilities around the world.
The new state-of-the-art development facility will incorporate an early stage laboratory and is currently under construction.
Making the announcement the Tánaiste said: "This is a highly strategic project for the pharmaceutical industry and will significantly enhance Ireland's image as a location for innovative R&D.
"In addition, as it involves the co-location of substantial R&D and manufacturing it will be a leading example to other global companies of what can be achieved in Ireland.
"This investment is excellent news for the Cork site."
This year Pfizer is celebrating forty years in Ireland. Its Ringaskiddy site, employing over 550 people, consists of four API (bulk pharmaceutical) plants producing a range of material for many of Pfizer’s major products. Pfizer, which has eight
different operations in Ireland employing a total of 2,000 people.
Dr Paul Duffy, VP Pfizer Manufacturing Ireland/Singapore said: "Pfizer in Ireland has a proven track record in relation to process improvement and optimisation. The decision to invest in the Cork PDC was based on demonstrated technical competence with similar projects and the successful completion of a number of R&D programmes."
(DW/BMcC)
Related Northern Ireland Recruitment News Stories
Click here for the latest headlines.
26 October 2015
Pfizer To Create Around 130 Jobs In Ireland
Pfizer has announced it is to create approximately 130 jobs across three manufacturing sites in Ireland. The jobs will be created at Grange Castle in Dublin, Little Island and Ringaskiddy in Cork. A recruitment drive is already underway.
Pfizer To Create Around 130 Jobs In Ireland
Pfizer has announced it is to create approximately 130 jobs across three manufacturing sites in Ireland. The jobs will be created at Grange Castle in Dublin, Little Island and Ringaskiddy in Cork. A recruitment drive is already underway.
11 July 2013
140 Construction Jobs To Be Created In Pfizer Expansion
Labour Deputy Robert Dowds, has welcomed the €130 million investment announced by Pfizer today, in two of its sites in Grange Castle, Dublin and Ringaskiddly in Co. Cork. He said: "This news is a strong indication of confidence in the Irish economy by a prominent multinational and major employer.
140 Construction Jobs To Be Created In Pfizer Expansion
Labour Deputy Robert Dowds, has welcomed the €130 million investment announced by Pfizer today, in two of its sites in Grange Castle, Dublin and Ringaskiddly in Co. Cork. He said: "This news is a strong indication of confidence in the Irish economy by a prominent multinational and major employer.
05 March 2014
VCE To Create 150 New Jobs In Cork
Minister for Jobs, Enterprise and Innovation, Richard Bruton TD, has announced that technology company, VCE, plans to create up to 150 new R&D positions at its international headquarters in Cork, Ireland. The investment is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.
VCE To Create 150 New Jobs In Cork
Minister for Jobs, Enterprise and Innovation, Richard Bruton TD, has announced that technology company, VCE, plans to create up to 150 new R&D positions at its international headquarters in Cork, Ireland. The investment is supported by the Department of Jobs, Enterprise and Innovation through IDA Ireland.
06 August 2008
180 Pfizer Jobs To Go In Cork
Pharmaceutical giant Pfizer is to shed 180 Cork jobs after failing to find a buyer for one of its five Irish manufacturing plants. During the past year and a half the firm has attempted to sell its Little Island facility under the terms of a going concern, in order to hold onto workers.
180 Pfizer Jobs To Go In Cork
Pharmaceutical giant Pfizer is to shed 180 Cork jobs after failing to find a buyer for one of its five Irish manufacturing plants. During the past year and a half the firm has attempted to sell its Little Island facility under the terms of a going concern, in order to hold onto workers.
02 February 2011
UK Pfizer Site To Close
Pharmaceuticals giant Pfizer have announced plans to close its UK facility. The Kent based site, which employs 2,400 people, will close due to the company's reorganisation of its research and development (R&D) capacity across the world. It is expected that the majority of workers will be made redundant over the next two years.
UK Pfizer Site To Close
Pharmaceuticals giant Pfizer have announced plans to close its UK facility. The Kent based site, which employs 2,400 people, will close due to the company's reorganisation of its research and development (R&D) capacity across the world. It is expected that the majority of workers will be made redundant over the next two years.